JAMA Oncology

JAMA Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology. JAMA Oncology is a member of the JAMA Network family of journals, which includes JAMA, 11 JAMA Network specialty journals, and JAMA Network Open.JAMA Oncology is published online weekly, every Thursday, and in 12 print/online issues a year. The journal receives over 1.1 million online visits annually and more than 1.5 million article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program.JAMA Oncology's acceptance rate is 11% for research articles. The median time to first decision is 1 day, and 33 days with review. All major articles are published online first. The journal's Impact Factor is 20.9, one of the highest ranking among oncology journals. The founding Editor in Chief of JAMA Oncology is Mary L. (Nora) Disis, MD. Dr. Disis is a Professor of Medicine and Adjunct Professor of Pathology and Obstetrics and Gynecology at the University of Washington (UW), and a member of the Fred Hutchinson Cancer Research Center. She is the Associate Dean for Translational Science in the UW School of Medicine, Director of the UW Center for Translational Medicine and Women's Health, and Director, UW Institute for Translational Health Sciences. Dr Disis is an expert in breast and ovarian cancer, immunotherapy, and translational research. JAMA OncologyISSN 2374-2437 (Print)ISSN 2374-2445 (Online)